TASIN-1TASIN-1 - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-116572A-01.804-HY-116572A-01804-HY-116572A-01Business & Industrial > Science & LaboratoryTASIN-1
Gentaur
EUR12027-02-21

TASIN-1

CAT:
804-HY-116572A-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
TASIN-1 - image 1

TASIN-1

  • Description:

    TASIN-1 is a selective inhibitor of truncated APCTR (adenomatous polyposis coli gene) that exerts cytotoxic effects by inhibiting cholesterol biosynthesis. TASIN-1 specifically targets colorectal cancer (CRC) cells carrying APC truncated mutations, while having no significant toxicity to wild-type APC cells. TASIN-1 exerts cytotoxic effects by targeting Emopamil binding protein (EBP) to inhibit cholesterol biosynthesis, triggering endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) generation, and JNK-mediated apoptosis, and inhibiting Akt survival signaling. TASIN-1 can be used to prevent and intervene in APC mutant colorectal cancer[1][2][3].
  • UNSPSC:

    12352005
  • Target:

    Apoptosis; Caspase; JNK; Reactive Oxygen Species (ROS)
  • Type:

    Reference compound
  • Related Pathways:

    Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/tasin-1.html
  • Concentration:

    10mM
  • Purity:

    98.09
  • Solubility:

    DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    CC1CCN(C2CCN(S(=O)(C3=CC=C(OC)C=C3)=O)CC2)CC1
  • Molecular Formula:

    C18H28N2O3S
  • Molecular Weight:

    352.49
  • References & Citations:

    [1]Zhang L, et al. Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer. Sci Transl Med. 2016 Oct 19;8 (361) :361ra140.|[2]Zhang L, et al. Cholesterol Depletion by TASIN-1 Induces Apoptotic Cell Death through the ER Stress/ROS/JNK Signaling in Colon Cancer Cells. Mol Cancer Ther. 2018 May;17 (5) :943-951.|[3]Wang W, et al. Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC) . J Med Chem. 2019 May 23;62 (10) :5217-5241.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Isoform:

    Caspase 3; Caspase 7
  • CAS Number:

    [792927-06-1]